Page 52 - Roche Low Code Enablement Application Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche low code enablement application platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Low Code Enablement Application Platform Today - Breaking & Trending Today

Roche's Tecentriq Gets EC Nod As Adjuvant Treatment For Certain People With Early-stage NSCLC

SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG's (RHHBY) blockbuster drug Tecentriq has been approved by the European Commission for yet another lung cancer indication - this time, as an adjuvant ....

United Kingdom , Levi Garraway , European Commission , Head Of Global Product Development , Roche Holding , Chief Medical Officer , Global Product ,

Roche: EU Approves Lunsumio To Treat Relapsed Or Refractory Follicular Lymphoma

SOUTH SAN FRANCISCO (dpa-AFX) - Swiss drug major Roche Holding AG (RHHBY) announced Wednesday that the European Commission has granted conditional marketing authorisation for the CD20xCD3 T-cell ....

European Commission , Roche Holding ,

How do we test for monkeypox?

Right now, only certain labs can test but that might change soon. ....

United States , Drugs Administration , World Health Organization , North America , Monkeypox Control , Epidemic Control , Rapid Testing , Edited By Walter Frick , Public Health ,

Roche develops unique PCR tests to detect monkeypox virus

Roche and its subsidiary TIB Molbiol have developed three different LightMix® Modular Virus kits for the detection of the monkeypox virus ....

Central African Republic , United States , Central African , Thomas Schinecker , Lightmix Modular Virus , North America , West African ,

Thousands to potentially benefit from Roche treatment for sight loss

Faricimab is administered as an eye injection with an interval of up to 16 weeks - News - PharmaTimes ....

Cathy Yelf , Helen Knight , National Institute For Health , Macular Society , National Institute , Care Excellence , Sight Loss ,